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Matrix Metalloproteinase-9 Amplifies the Immune
Response to Pseudomonas aeruginosa
Corneal Infection
Sharon A. McClellan, Xi Huang, Ronald P. Barrett, Shahrzad Lighvani, Yunfan Zhang,
Dawn Richiert, and Linda D. Hazlett
PURPOSE. The purpose of this study was to determine the role
of matrix metalloproteinases (MMP) in Pseudomonas aeruginosa keratitis.
METHODS. Gene array and selective real-time PCR examined
MMP expression in the cornea of susceptible (C57BL/6, B6)
versus resistant (BALB/c) mice before and after infection; zymography tested enzyme activity for MMP-2 and -9. Clinical
score, Langerhans cell (LC), and Neutrophil (PMN) quantitation were done in recombinant (r) MMP-9, antibody neutralized, and MMP-9–/– mice. The chemotactic potential of MMP-9
was tested in a Boyden chamber assay; light and transmission
microscopy and immunostaining for collagen IV and MMP-9
were used to examine the effects and the source of MMP-9
after infection. ELISA was used to assess IL-1␤ and MIP-2 levels.
RESULTS. Gene array (confirmed by PCR) revealed sixfold more
MMP-9, and zymography showed greater enzyme activity in the
infected cornea of B6 over BALB/c mice. rMMP-9 injection of
BALB/c mice enhanced, whereas MMP-9 antibody neutralization in B6 mice and its absence in MMP-9–/– mice decreased
corneal disease. MMP-9–/– and antibody neutralized mice had
fewer LCs in cornea; rMMP-9-treated mice had more. A myeloperoxidase (MPO) assay showed a similar pattern for PMN.
MMP-9 was not chemotactic for LC or PMN. The basement
membrane was more intact in MMP-9–/– over wild-type infected mice and correlated with staining for collagen IV; PMN
was a source of MMP-9. IL-1␤ and MIP-2 were increased in
rMMP-9 but decreased in MMP-9 antibody neutralized and
MMP-9–/– over control groups.
CONCLUSIONS. MMP-9 regulates immune function in cornea by
proteolysis, potentiating P. aeruginosa keratitis by degrading
collagen IV and upregulating chemotactic cytokines/chemokines IL-1␤ and MIP-2. (Invest Ophthalmol Vis Sci. 2006;47:
256 –264) DOI:10.1167/iovs.05-1050
Pseudomonas aeruginosa is a gram-negative organism associated worldwide with bacterial keratitis, particularly in
extended-wear contact lens users.1 Most complications of
bacterial keratitis are structural alterations of the cornea, but
secondary glaucoma and cataract also may occur. These
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responses are largely caused by the host’s inflammatory
response, but the influence of bacterial toxins, toxicity from
treatment, and increased antibiotic resistance2 remain of
importance. In the United States, microbial keratitis is most
frequently associated with complications from contact-lens
wear. With an incidence of 25,000 to 30,0000 cases annually, and the cost of treatment estimated at between $15 and
$30 million, the disease poses a considerable medical and
economic impact.3
Animal models of disease, produced by topical application
of bacteria after wounding the corneal epithelium, by intrastromal inoculation, or by placement of a contaminated
contact lens or suture on the cornea4 have contributed to
our understanding of disease pathogenesis. In mice, corneal
infection induced experimentally with this pathogen causes
corneal perforation in B6 (susceptible) Th1 responder mice,5
whereas BALB/c (resistant), a Th2 dominant strain,5 resolves
the infection.6 Extensive studies using these models have provided information regarding the role of inflammatory cells
(e.g., Neutrophils [PMN], T and natural killer cells, macrophages, and Langerhans cells [LCs]), as well as cytokines and
chemokines in modulating inflammation, innate immunity, and
Th1 versus Th2 responses7–11 to P. aeruginosa in the eye.
However, the potential role of matrix metalloproteinases
(MMP) in immunomodulation of corneal infection and inflammation remains little explored.12–15
MMPs are a family of protein-cleaving enzymes that degrade
extracellular matrix and basement membrane components.16
The most widely studied members of the MMP family in eye
tissues are the gelatinases MMP-2 and MMP-9, because they
preferentially degrade basement-membrane components such
as type IV collagen.17 Recently, MMP-9 also has been found to
process cytokines and chemokines, and thus is a prototypic
example of the regulation of immune functions through proteolysis.
In the present study, we investigated the expression pattern
of several MMPs in the cornea of susceptible B6 versus resistant
BALB/c mice. Our data suggest that MMP-9 has an important
role in corneal pathogenesis, that it is required for the transmigration of PMN and LC into the infected cornea, that it does
not provide a direct chemotactic signal, that its effect is indirect through regulation of cytokines IL-1␤ and MIP-2, and that
PMNs are a major source of the enzyme.

MATERIALS

AND

METHODS

Infection of Mice
Eight-week old female C57BL/6 (B6), BALB/c, MMP-9 knockout (–/–)
and FVB wild-type (WT) mice (Jackson Laboratory, Bar Harbor, ME)
were used. For infection, the cornea was scarified as described before6
and a 5 L bacterial suspension containing 1.0 ⫻ 106 colony forming
units of P. aeruginosa strain 19,660 (American Type Culture Collection [ATCC]) was applied. Disease was monitored from 1 to 5 days
postinfection (p.i.)7 and mice were killed at 1, 5, or 6 days p.i. Animals
were treated in compliance with the Association for Research in Vision
Investigative Ophthalmology & Visual Science, January 2006, Vol. 47, No. 1
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and Ophthalmology Statement for the Use of Animals in Ophthalmic
and Vision Research.

Ocular Response to Infection
Disease was graded as before,18 from 0 to 4, with 0 being clear or slight
opacity partially covering the pupil and ⫹4, corneal perforation. A
clinical score was recorded for each mouse for statistical comparison
(n ⫽ 10/group/treatment).

Gene Array and Real-Time PCR
Data for the gene array analysis of MMPs was from a previous study and
was analyzed as before.9 For real-time PCR, total RNA was isolated from
individual uninfected corneas at 1 and 5 days p.i. (n ⫽ 5/time/group)
by using total RNA isolation reagent (RNA STAT-60; TEL-TEST Inc.,
Friendswood, TX). Reverse transcription was done by using 0.5 g of
oligo(dT)12–18 primer with 1 g of total RNA and heating to 65°C for
5 minutes, then immediately chilling on ice. After addition of a
200-U/L aliquot of M-MLV reverse transcriptase (Invitrogen Life Technologies, Carlsbad, CA), the mixture was heated to 37°C for 1 hour.
PCR was done using 1 L of cDNA in 25 L PCR reaction by using
primers for ␤-actin: 5⬘-GATTACTGCTCTGGCTCCTAGC-3⬘ (sense) and
5⬘-GACTCATCGTACTCCTGCTTGC-3⬘ (antisense), MMP-9: 5⬘-CTCTACAGAGTCTTTGAGTCCGGCAG-3⬘ (sense) and 5⬘-TAC GGAACTTCCAGTACCAACCGTC-3⬘ (antisense), and MMP-2: 5⬘-ACACTGGGACCTGTCACTCC-3⬘ (sense) and 5⬘-CCAAATAAACCGGTCCTTGA-3⬘ (antisense).
Samples were run twice using a cycler system (Cepheid Smart Cycler
System; Cepheid Inc., Sunnyvale, CA). A standard curve of fivefold serial
dilutions of cDNA was used with a correlation coefficient (R2 ⬎ 0.99). The
fold difference in expression of MMP-2 and -9 in 1 day and 5 days p.i.
versus normal cornea was calculated after each CT was normalized to
␤-actin.

Zymography
Gelatin zymography was performed as described before12 on individual normal corneas (n ⫽ 5/time/group) at 1 and 6 days p.i. from B6 and
BALB/c mice. Briefly, corneal samples were homogenized in 250 L
lysis buffer (25 mM Tris-HCl, pH 7.5; 100 mM NaCl; and 1% v/v Nonidet
P-40) containing 10 g/mL aprotinin, 2 g/mL leupeptin, and 4 mM
benzamidine. Samples were frozen at ⫺80°C and when used were
diluted in ⫻4 sample buffer to appropriate concentration (standards at
0.5 ng/lane and corneal samples at 100 g/lane) and were loaded onto
10% polyacrylamide gels containing 0.1% gelatin. Gels were run for 90
minutes at 100 v, then the separated enzymes were renatured by
incubating the gels in 2.5% Triton X-100 for 30 minutes at room
temperature to remove SDS, then overnight (16 to 20 hours) in developing buffer with calcium for gelatin digestion. To visualize the activated MMPs, gels were stained in 0.5% stain (Coomassie brilliant blue;
Sigma, St. Louis, MO) for 1 hour, then destained in 10% methanol and
5% acetic acid until clear bands showing enzyme activity were visible.
MMP-2 and -9 standards (R&D Systems, Minneapolis, MN) were run in
parallel to compare digested bands. To confirm that the bands were
metalloproteinases, separate gels were incubated overnight in buffer
lacking calcium and containing 20 mM EDTA. Gels were incubated
overnight at 37°C and, after the incubation period, were stained and
destained as described above.

Antibody and Recombinant Protein Treatment
To neutralize MMP-9 in susceptible B6 mice, 10 g of mouse antihuman MMP-9 antibody (Ab) (Calbiochem, San Diego, CA) was injected subconjunctivally 1 day before infection. An additional 150 g
was injected intraperitoneally (i.p.) on the day of infection (day 0), and
on days 2 and 4 p.i. Control mice were injected with mouse IgG.
Resistant BALB/c mice were given 1 g of rMMP-9 protein (R&D
Systems) subconjunctivally 1 day before infection and an additional 1
g i.p. on both 1 and 3 days p.i. Control BALB/c mice received similar
PBS injections.
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Myeloperoxidase Assay
An myeloperoxidase (MPO) assay quantitated PMN in the cornea of Abversus control-treated B6, recombinant- versus PBS-treated BALB/c, and
FVB (WT) versus MMP-9–/– mice (n ⫽ 5/group) at 5 days p.i. as
described.11 One unit of MPO activity is equivalent to ⬃2 ⫻ 105
PMN/mL.19

LC Staining
Epithelial sheets were harvested at 6 days p.i. from IgG versus Ab
neutralized B6, PBS versus rMMP-9-treated BALB/c, and FVB versus
MMP-9–/– mice (n ⫽ 3/group) and stained with adenosine diphosphate
(ADP) as described.20,21 Representative areas were photographed at
⫻25 on a microscope (Axiophot; Carl Zeiss, Morgan Instruments,
Cincinnati, OH). LCs were counted on prints of the photographed
fields and numbers are represented as number of LC per field ⫾ SEM.

Cell Culture and Chemotaxis
LC Culture. LCs (XS52 cell line) were cultured (all reagents from
Gibco, Carlsbad, CA) in complete RPMI (with 10% fetal calf serum
[FCS]) supplemented with 0.5 ng/mL murine recombinant granulocyte
macrophage– colony-stimulating factor and 5% fibroblast (NS line, cultured in complete Roswell Park Memorial Institute medium 1640
[RPMI] with 10% FCS) supernatant. Cells that lifted from confluent
cultures were collected and resuspended in migration medium (RPMI
1640 with 0.5% BSA) to a concentration of 1 ⫻ 106 cells/mL. These
cells expressed DEC-205 and did not stain with antibodies against B7 to
1 or B7 to 210 costimulatory molecules, indicating that they are immature (data not shown).
Chemotaxis Assay. A 48-well microchemotaxis chamber (Neuroprobe, Bethesda, MD) with an 8-m-pore-size filter (coated [0.5
mg/mL] with collagen IV) separating the upper and lower chambers
was used to test the chemotactic effect of MMP-9. RPMI 1640/0.5% BSA
served as the migration medium and also provided a negative control.
A total of 30 L each of RANTES (positive control, 10– 6 M; Sigma),
RPMI 1640/0.5% BSA, (negative control), or MMP-9 (0.1 and 0.01 g)
were put in the lower wells, and 50 L of an LC cell suspension
(50,000 cells/well) was placed in the chamber upper wells and incubated at 37°C with 5% CO2 for 30 to 45 minutes. Nonmigrated cells
were wiped off the back side of the filter after staining (Diff-Quick;
Fisher Diagnostics, Middletown, VA). The stained filter was placed on
a microscope slide and allowed to dry. Migrated cells were counted for
each well, and data were expressed as the mean number of migrating
cells ⫾ SEM.
PMNs were induced into the peritoneal cavity of B6 and BALB/c
mice, harvested as described,22 diluted to 10,000 to 20,000 cells/well
(purity ⬎90%) and similarly tested in chemotaxis assays by using
uncoated polycarbonate filters with a 3.0-m pore size. The chemoattractants were similar to above, with the exception that MIP-2 (0.001
g; R&D Systems) was used as the positive control. Migrated cells were
counted as above.

Light Microscopy and Transmission
Electron Microscopy
Eyes were enucleated from FVB and MMP-9–/– mice at 5 days p.i. (n ⫽
2/group), rinsed in PBS, and fixed in 1% osmium tetroxide, 2.5%
glutaraldehyde, and 0.2 M Sorensen phosphate buffer (pH 7.4; 1:1:1) at
4°C for 3 hours. Specimens were dehydrated in graded ethanols and
embedded in plastic, sectioned, and photographed as described.23

Immunostaining
Eyes were enucleated at 5 days p.i. from FVB and MMP-9–/– mice (n ⫽
3/group), along with the uninfected contralateral eyes, embedded in
optimum cutting temperature compound, and frozen in liquid nitrogen. Sections (10 m) were collected onto poly-lysine coated slides
and were placed at 37°C for 2 to 4 hours. Slides were fixed in cold
acetone for 2 minutes and air-dried. Nonspecific reactivity was blocked
with 0.01M PBS containing 1% BSA, 0.05% Tween 20, and 2% normal
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TABLE 1. Expression Pattern of Genes in Cornea
Gene Class

Average Fold Differences

Access No.

Name

BALB/c:
1 day p.i. vs. n

B6:
1 day p.i. vs. n

NM_008610
NM_010809
NM_008611
NM_013599
NM_019471
NM_008606

MMP-2
MMP-3
MMP-8
MMP-9
MMP-10
MMP-11

1.5
3.4
3.4
5.5
9
2.2

1.2
10.8
4.6
32.8
10.2
1.3

a 50-L aliquot was assayed. The reported sensitivity of these assays is
⬍1.5 pg/mL for MIP-2, and ⬍3.0 pg/mL for IL-1␤.

Statistical Analysis
The difference in clinical score at each experimental time point between two groups was tested by the Mann–Whitney U test. An unpaired, two-tailed Student’s t-test was used to determine the significance for mRNA, MPO, LC number, and for chemotaxis data.
Differences were considered significant at P ⱕ 0.05. Each experiment
was repeated at least once, and data from a typical experiment are
shown.

Affymetrix microarray x3 separate experiments. p.i., postinfection.

RESULTS

goat serum for 30 minutes at room temperature (RT). Slides were
incubated overnight at 4°C with rabbit anti-type IV collagen Ab (Research Diagnostics, Flanders, NJ) diluted 1:50 with blocking buffer.
After a 30-minute incubation with 0.3% hydrogen peroxide, biotin
conjugated goat anti-rabbit IgG (H⫹L) secondary Ab (1:100; Jackson
ImmunoResearch, West Grove, PA) with 0.1 M Tris-HCl was applied,
and the slides were incubated for 1 hour at RT. Sections were washed
and incubated with a 1:100 dilution of peroxidase conjugated modified
egg white avidin (ExtrAvidin; Sigma) for 30 minutes, then positive
staining was visualized with metal-enhanced diaminobenzidine (Pierce,
Rockford, IL).
Immunostaining also identified the cell source of MMP-9. These
eyes from B6 (n ⫽ 3 eyes) mice were enucleated at 3 days p.i., fixed
in 0.01 M sodium periodate, 0.05 M lysine, and 2% paraformaldehyde
in 0.1M phosphate buffer (pH 7.4) overnight at 4°C and processed for
paraffin embedding as described before.24 Slides were processed, and
nonspecific binding was blocked with 1.5% normal rabbit serum and
2% BSA in PBS-saponin, drained dry, and incubated with a goat antihuman MMP-9 Ab (1:200) for 2 hours, and then with a biotinylated
secondary rabbit anti-goat Ab (1:100) for 1 hour. Slides were rinsed and
incubated with modified egg white avidin (1:100; ExtrAvidin; Sigma)
for 30 minutes in a moist chamber, rinsed with Tris-HCL buffer and
drained dry. Control sections were incubated similarly but with the
omission of the primary Ab. For routine morphology, slides were
deparaffinized and rehydrated as for immunostaining, allowed to dry,
stained with 1% methyl green for 2 minutes at RT, rinsed, and mounted
as above.

ELISA Analysis of Cytokines
Cytokine protein levels were determined by using ELISA kits (R&D
Systems). Corneas were harvested at 5 days p.i. (n ⫽ 5/group/time),
individually homogenized in 1.0 mL PBS with 0.5% hexadecyltrimethylammonium bromide (HTAB) with a glass micro tissue grinder (Fisher
Scientific, Hanover Park, IL) and centrifuged at 13,000g for 10 minutes.
Sample supernatants were diluted (1:10 for IL-1␤; 1:50 for MIP-2), and

Gene Expression
Analysis of gene array data for MMPs in cornea at 1 day p.i.
(Table 1), showed that fold increases in gene expression were
greatest between the two mouse strains for MMP-9 (sixfold
more in B6 over BALB/c mouse cornea), with little difference
between the others (MMP-2, -3, -4, -10. or -11).

RT-PCR
RT-PCR (Figs. 1A, 1B) confirmed the gene array data for MMP-9
(Fig. 1B) at 1 day p.i. (P ⫽ 0.004), which was elevated when
compared with levels in the normal cornea and also showed
that, at 5 days p.i., there was no difference in mRNA levels
between the two groups (P ⫽ 0.31). RT-PCR did not confirm
the pattern of MMP-2 (similar fold increases over normal in
both groups of mice) seen in gene array analysis, however.
MMP-2 was decreased in both groups when compared with
normal levels (P ⫽ 0.01). At 5 days p.i., BALB/c over B6 mice
had significantly (P ⫽ 0.0004) increased levels of mRNA for
MMP-2.

Zymography
Zymography (Fig. 2) showed that the normal cornea of B6 and
BALB/c mice did not exhibit detectable latent or active enzyme
levels of MMP-9 or MMP-2 (lanes 3 and 4) at the protein
concentration tested. At 1 day p.i., both groups of mice
showed both latent and active MMP-9 (lanes 5 and 6) but not
MMP-2. By 6 days p.i., (lanes 7 and 8) BALB/c mice showed
similar levels of MMP-9 in the cornea when compared with 1
day p.i., while activity appeared increased in the B6 cornea.
The digested bands were confirmed as metalloproteinases (including degraded MMP-9 in the B6 cornea), because they were
not detectable (lane 9, from a separately run gel) when calcium
was removed by using EDTA.

FIGURE 1. Real-time RT-PCR for MMP-2 (A) and MMP-9 (B) mRNA levels in B6 vs. BALB/c normal cornea
and at 1 and 5 days p.i. The MMP-9 data confirms the pattern of gene expression shown in Table 1 at 1
day p.i. and were significant (P ⫽ 0.004); differences were not significant at 5 days p.i. (P ⫽ 0.31). The
MMP-2 data does not confirm the pattern shown in Table 1 at 1 day p.i.; the data were significant at 1 day
(P ⫽ 0.01) and 5 days (P ⫽ 0.004) p.i.
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FIGURE 2. Zymography of MMP-2 and MMP-9 activity in normal cornea and at 1 and 6 days p.i. No enzyme
activity was detected in the normal cornea of either mouse strain. At 1 day p.i., MMP-9 activity was
detected in both groups of mice (appeared slightly increased in B6 over BALB/c). By 6 days p.i., activity
was unchanged in BALB/c cornea but enhanced in the cornea of B6 mice. No MMP-2 (latent or active) was
detected in either group of mice. Lane 9 (from a separate gel) shows that the detected latent and active
enzyme activity for MMP-9 are Ca⫹ dependent (confirming that they are metalloproteinases) and that no
activity is detected when Ca⫹ is chelated with EDTA. MMP standards in lanes 1 and 2 (0.5 ng/lane) and
corneal samples in lanes 3 to 9 (100 g/lane).

Clinical Score
Based on these data, suggesting that MMP-9 gene and protein
levels were greater in the cornea of susceptible versus resistant
mice, BALB/c mice were injected with rMMP-9, whereas B6
mice were injected with an anti-MMP-9 Ab; MMP-9 deficient
mice also were tested and compared with WT controls. Clinical scores (Figs. 3A, 3B, 3C) showed that BALB/c mice injected
with rMMP-9 versus PBS had significantly increased disease at
1, 3, and 5 days p.i., P ⫽ 0.01, 0.004, and ⬍0.0001, respectively (Fig. 3A). In B6 mice injected with Ab against MMP-9, the
reverse was apparent. Less disease was seen in these mice
compared with IgG-injected control animals at 1, 3, and 5 days
p.i., P ⫽ 0.02, 0.05, and 0.004, respectively (Fig. 3B). Infection
of MMP-9–/– versus WT FVB mice confirmed the Ab neutralization data and showed that MMP-9–/– mice showed a decreased
level of disease; none of the infected corneas of knockout mice
had perforated at 5 days p.i., while a significant number of WT
corneas had (P ⫽ 0.009, 0.0008, and 0.0004, for 1, 3, and 5
days p.i., respectively; Fig. 3C).

LC
Because LCs are one of the most efficient types of migrating
antigen presenting cells, we tested whether injecting rMMP-9
into BALB/c, Ab neutralizing MMP-9 in B6 and MMP-9 deficiency in the knockout mice changed the number of LCs in the
cornea at 6 days p.i. (Figs. 4A, 4B, 4C). Injection of rMMP-9
versus PBS significantly increased the number of LC in the
infected BALB/c cornea (Fig. 4A, P ⬍ 0.0001). In MMP-9 Ab
neutralized and knockout animals, LC were reduced significantly compared with their appropriate controls (Fig. 4B, P ⬍
0.0001 and Fig. 4C, P ⫽ 0.0003).

PMN
Because PMNs are the most numerous cells responding to P.
aeruginosa corneal infection, they were quantitated by using
an MPO assay at 5 days p.i. in the cornea of the three groups of
mice (rMMP-9, Ab-neutralized, and knockout mice) (Figs. 5A,
5B, 5C). PMNs were increased in the BALB/c cornea (Fig. 5A,
P ⬍ 0.0001) after rMMP-9 treatment. In contrast, in Ab neutralized B6 mice (Fig. 5B) and in knockout (Fig. 5C) over their
respective controls, MPO activity was decreased significantly
(Fig. 5B, P ⫽ 0.01; Fig. 5C, P ⫽ 0.03).

Chemotaxis
We tested whether MMP-9 induced chemotaxis in the two cell
populations (Figs. 6A, 6B, 6C). When compared with the neg-
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FIGURE 3. Clinical scores are shown for rMMP-9 treated BALB/c mice
(A), for anti-MMP-9 Ab-treated B6 mice (B), and for MMP-9–/– and FVB
WT controls (C). Significant differences were detected at 1, 3, and 5
days p.i. (A) P ⫽ 0.01, 0.004, ⬍0.0001; (B) P ⫽ 0.02, 0.05, 0.004; (C)
P ⫽ 0.009, 0.0008, 0.0004.
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the TEM level, cells were observed closely associated with a
more intact basal lamina (Fig. 7D) in the knockout mouse
cornea and with regions where the basal lamina was interrupted in the FVB (Fig. 7C) control.

Immunostaining
To examine collagen IV integrity, immunostaining was performed; the data are shown in Figures 8A, 8B, 8C, 8D). Staining
for collagen IV was more even and uninterrupted in the peripheral cornea in the MMP-9–/– (Fig. 8B) over WT (Fig. 8A)
cornea compared favorably with the immunostaining pattern
in the normal, uninfected cornea (Fig. 8C). No staining was
observed in the absence of the primary antibody (Fig. 8D).
Immunostaining was used to determine the cell source of
MMP-9 in B6 cornea at 3 days p.i. (Figs. 9A, 9B, 9C, 9D, 9E, 9F).
Staining for MMP-9 was associated with cells marginated within
blood vessels in the paracentral cornea (Figs. 9A, 9C) and in the
anterior chamber (Fig. 9E). Routine morphology of these two

FIGURE 4. Quantitation of LC (stained by ADPase) in BALB/c mice
treated with rMMP-9 (A), B6 mice treated with anti-MMP-9 Ab (B), and
MMP-9–/– mice and their WT control (C). LC were significantly increased (P ⬍ 0.0001) in BALB/c cornea after rMMP-9 treatment; B6
mice treated with aMMP-9 Ab showed a decreased (P ⬍ 0.0001)
number of LC over controls. MMP-9–/– mice also showed fewer (P ⫽
0.0003) LC than FVB WT mice. Fifteen fields were counted for each
group.

ative media control MMP-9 at high (0.1 g) or low (0.01 g)
concentration had no chemotactic activity for LC (Fig. 6A, P ⫽
0.64 and 0.1). RANTES served as the positive control. PMN
from B6 and BALB/c mice were tested similarly for chemotaxis
to MMP-9 (Fig. 6B upper and lower graphs). When compared
with the media control, there was no difference in chemotaxis
of PMN at either concentration of MMP-9 (as above) for either
B6 (P ⫽ 0.13 and 0.41) or BALB/c (P ⫽ 0.2 and 0.3) mice.
MIP-2 was the positive control.

Light Microscopy and Transmission
Electron Microscopy
–/–

The corneas of infected MMP-9 and WT (FVB) control mice
were examined microscopically at 5 days p.i. (Figs. 7A, 7B, 7C,
7D). MMP-9–/– mice (Fig. 7B) exhibited a more intact basal
lamina beneath the peripheral corneal epithelium than WT
mice (Fig. 7A). PMNs were numerous, and when examined at
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FIGURE 5. MPO (PMN) activity in the cornea 5 days p.i. in BALB/c
mice after rMMP-9 treatment (A), B6 mice after anti-MMP-9 Ab treatment (B), and in MMP-9–/– vs. control mice (C). (A) PMN were increased (P ⬍ 0.0001) in BALB/c cornea after rMMP-9 over control
treatment; (B) PMN were reduced significantly (P ⫽ 0.01) after antiMMP-9 Ab treatment of B6 mice and (C) in MMP-9–/– over WT controls
(P ⫽ 0.03)
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FIGURE 7. Light (A, B) and transmission EM (C, D) at 5 days p.i. The
peripheral cornea of a FVB WT mouse (A, C) shows disrupted basement membrane (arrows) associated with an inflammatory cell infiltrate. The MMP-9–/– mouse cornea (B, D) exhibits an intact basement
membrane (arrowhead), despite the heavy cellular (mostly PMN)
infiltrate. Magnification: (A, B) ⫻550; (C, D) ⫻6000

enous absence of MMP-9 also resulted in reduced IL-1␤ (Fig. 10
C, P ⬍ 0.0001) and MIP-2 (Fig. 10F, P ⫽ 0.03) levels in
knockout compared with WT mice.

DISCUSSION

FIGURE 6. (A) Chemotaxis assay for cell migration of LC (cell line
XS52). RANTES was the positive and media were the negative control.
MMP-9 had no significant chemotactic activity for LC (P ⫽ 0.64 and 0.1
compared with media control at 0.1 and 0.01 mg, respectively). (B)
Chemotaxis assay for cell migration of PMN isolated from B6 vs.
BALB/c mice. MIP-2 was the positive and media were the negative
control. MMP-9 at 0.1 and 0.01 mg/mL showed no significant PMN
chemotactic activity in B6 (B, upper panel; P ⫽ 0.13 and 0.41) or
BALB/c (B, lower panel; P ⫽ 0.2 and 0.3) mice over media control.

MMPs are secreted enzymes with major functions in the degradation and remodeling of extracellular matrix25 and in the
pathology of inflammatory diseases of the connective tissues.26
In the eye, corneal degradation and ulceration is often observed after exposure to infectious agents such as P. aeruginosa or herpes simplex virus, after chemical or thermal injury
to the cornea, or in association with diseases such as rheumatoid arthritis or vitamin A deficiency.27–32 In P. aeruginosa
corneal infection, Kernacki et al.12 showed that when compared with susceptible (cornea perforates) nonimmunized
mice, resistant immunized animals displayed lower levels of

areas (Figs. 9C, 9E) showed the distinct multi-lobulated pattern
characteristic of PMN nuclei, confirming their identity. Control
sections in which the primary Ab was omitted from the reaction were negative for staining (Figs. 9B, 9D, 9F).

ELISA
To test MMP-9 interactions with cytokines and chemokines in
modulating corneal disease, protein analysis of IL-1␤ and MIP-2
was done 5 days p.i. after rMMP-9 treatment of BALB/c (Figs.
10A, 10D), Ab neutralization of B6 (Figs. 10B, 10E) and in
MMP-9–/– (Figs. 10C, 10F) and appropriate control groups of
mice. Injection of rMMP-9 in BALB/c mice significantly enhanced both IL-1␤ (Fig. 10〈) and MIP-2 (Fig. 10D) levels in the
infected cornea (P ⬍ 0.0001 for both). Ab neutralization of
MMP-9 in B6 mice significantly decreased levels of both IL-1␤
(Fig. 10B, P ⫽ 0.008) and MIP-2 (Fig. 10E, P ⫽ 0.02). Endog-
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FIGURE 8. Staining for collagen type IV in FVB WT (A) vs. MMP-9–/–
mouse (B) cornea at 5 days p.i. Type IV collagen is disrupted in the
basement membrane of the WT (A) vs. the knockout mouse (B)
cornea. Type IV collagen also shown in the cornea of an uninfected,
control FVB mouse (C). An antibody control (normal serum) for immunostaining (D) is shown using 5 day p.i. cornea. No staining was
detected. Magnification, ⫻75.
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FIGURE 9. Staining for MMP-9 in infected cornea (A–F). Staining in the
B6 mouse infected eye at 3 days p.i. (A, C, E) vs. control sections (B,
D, F) shows staining for MMP-9 is the stroma and associated with cells
marginated within vessels in the peripheral cornea and in the anterior
chamber. Stromal vessels are shown in (C) and (E), the anterior
chamber is shown. Insets (C, E) show that the cells in the stroma and
anterior chamber are PMNs. Control sections in which the primary
antibody was omitted show no specific staining. Magnification: (A, B)
⫻15; (C, D, E, F) ⫻100.

both the active and latent forms of MMP-9. In the present
study, gene expression data were analyzed to provide a clue as
to which of the MMPs may be of importance in the genetically
susceptible B6 versus resistant BALB/c mouse models of P.
aeruginosa infection and to focus on the immune-associated
functions of the MMPs.
The greatest fold increases in MMP-9 were detected by gene
array in the infected cornea of B6 (susceptible) over BALB/c
(resistant) mice, and the data were confirmed by RT-PCR.
Furthermore, latent and active forms of MMP-9 only were
detected in the cornea by using zymography. This showed that
in the infected cornea, B6 mice appeared to have increased
levels of both forms of the enzyme when compared with
BALB/c mice. MMP-2 was not detected and, although unlikely,
might reflect that the amount of protein loaded was insufficient. Nonetheless, based on these data, we used MMP-9 Ab
neutralization and injection of rMMP-9 protein, as well as
MMP-9–/– mice to explore further the contribution of MMP-9 to
corneal immunopathology. By using a clinical scoring system,
rMMP-9 –injected resistant BALB/c mice exhibited worsened
disease, while Ab-neutralized B6 mice and MMP-9–/– mice had
less disease than control groups. These in vivo data are consistent with an in vitro rabbit corneal fibroblast model in which
cells treated with pseudomonal exoproteases or lipopolysaccharide (LPS) expressed secreted MMP-9.33 Various other studies have indicated that MMP-9 (or gelatinase B) is a key player
in the mechanisms underlying immunopathology. Active forms
of gelatinases 2 and 9 were detected in endogenous corneal
ulcer cases in tear fluid, and it was concluded that the active
form of gelatinase expression may be related to the severity of
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ulceration.34 In other infectious disease models using Candida
albicans, in vitro infection of human oral mucosal cells induced MMP-2 and MMP-9 gene activation, but importantly as in
this study, only the levels of active MMP-9 rose.35 In marked
contrast to these studies, Lee et al.36 showed that MMP-9,
among several other MMPs, is needed for resistance to P.
aeruginosa corneal and lung infection by using TIMP-1 mutant
mice. The conclusion that MMP agonists may be of therapeutic
benefit to augment resistance to the bacterium are not consistent with this report nor with extensive past studies with
murine and other corneal experimental bacterial infection
models.4
Whether MMP-9 was crucial for LC migration also was
tested. LCs are dendritic cells that capture foreign antigens and
migrate with them to regional lymph nodes where they are
presented to naı̈ve T cells. These cells have been shown to be
critical in the innate immune response to P. aeruginosa,8,10
and increased numbers of cells in the cornea have been associated with corneal perforation. When using the same paradigm of testing as described above, MMP-9 Ab neutralized and
knockout mice had fewer LCs in the infected cornea and
BALB/c mice injected with rMMP-9 had more, suggesting that
MMP-9 may be involved in LC transmigration into the cornea.
When tested, however, soluble MMP-9 did not have a chemotactic effect. In this regard, others have reported that membrane-associated MMP-2 and -9 rather than soluble MMPs appear involved in cell migration.37 Membrane-type MMPs (MT1
to 6) have been detected in the cornea of mice infected with P.
aeruginosa, and peak expression of all three showed a good
correlation with inflammation and stromal destruction,14,15 but
their role in LC chemotaxis remains untested in the cornea. On
the other hand, LC (epidermal), as well as other epidermal cells
have been shown to be capable of producing MMP-9 and may
themselves contribute to proteolysis associated with transmigration of LC in the induction phase of contact dermatitis.38
Also, it has been shown that MMP-9 may be involved in LC
morphologic and phenotypic maturation.39
In inflammation, leukocytosis and blood-cell homeostasis
are crucial in host defense. Gelatinase B assists in the peripherilization of leukocytes in response to chemokines into sites of
inflammation.40 Use of MMP-9 neutralization and MMP-9–/–
animals showed that PMNs are decreased in these two versus
control mouse groups. Consistent with these data, PMNs were
increased in the cornea of rMMP-9 injected mice, suggesting
that MMP-9 contributes to the regulation of PMN transmigration into the cornea. The heavy inflammatory infiltrate, consisting mainly of PMN, also was confirmed by LM and TEM in
the cornea of knockout versus control mice and also provided
evidence that a more intact basal lamina was present in the
cornea of MMP-9–/– versus WT animals. Immunostaining for
collagen IV confirmed an interrupted basal lamina in the WT
versus MMP-9–/– mouse cornea, possibly contributing to PMN
transmigration into the cornea.
Gelatinase B was first identified in PMN41 and later in
monocytes and macrophages.42 In general, these types of cells
secrete gelatinase A constitutively, but the expression of gelatinase B requires induction by adequate triggering.43 IL-1, lectins, double-stranded RNA, and LPS are soluble inducers of
MMP-9.43,44 In the present study, immunostaining showed that
PMNs in the cornea (and anterior chamber) were a source of
MMP-9 (gelatinase B). PMN gelatinase B has been shown to be
released in the extracellular medium as a latent proform and
then to be activated mainly by PMN elastase in a model of PMN
migration across a Matrigel basement membrane matrix coated
onto a filter in a Boyden chamber.45 However, others have
used gelatinase-B-deficient mice and intratracheal LPS challenge and have shown that gelatinase B is not required for PMN
emigration in the lungs, the peritoneum, and the skin.46
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FIGURE 10. ELISA for IL-1␤ and MIP-2
(A–F). IL-1␤ and MIP-2 levels were significantly elevated after rMMP-9 treatment (A, D; P ⬍ 0.0001 for both);
cytokine levels were reduced significantly after MMP-9 neutralization (B,
E; P ⫽ 0.008 and P ⫽ 0.02) and with
endogenous absence of the metalloproteinase. N ⫽ 5 mice/group/time/
cytokine. (C, F; P ⬍ 0.0001 and P ⫽
0.03).

MMP-9 has been shown to function as a regulator and
effector in leukocyte biology, because it is able to activate
pro-IL-1␤ into active IL-1␤.47 IL-1␤ and MIP-2 are important in
the susceptibility response of B6 mice48 and thus were examined in MMP-9 –Ab-neutralized and gene-knockout mice. Both
groups when compared with control groups had decreased
levels for each cytokine that were significant statistically. Nonetheless, the reduced chemokine level in FVB versus MMP-9–/–
mice was modest and so the biological relevancy may be
suspect. In contrast, rMMP-9-treated mice had enhanced levels
for IL-1␤ and MIP-2, suggesting that MMP-9 proteolysis modulates cytokine expression in the cornea. Because gelatinase B
and cytokines both function in the extracellular milieu and
might be secreted together at particular sites within tissues, it
is not unexpected that they would interact. In fact, others have
shown that treatment of mice with an anti-IL-1␤ antibody
before P. aeruginosa challenge resulted in a significant reduction of MMP-9. Together with the data from the present study,
the evidence suggests that, in the P. aeruginosa infected cornea, there is a reciprocal interaction between the two.49
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